A closed system drug transfer device (CSTD) is a closed system for cytotoxic drugs: its adapters lock to each other, so no needle and no open drop is left between vial, syringe, bag and patient. By the NIOSH definition it mechanically stops contaminants from entering the system and hazardous drug or vapour from leaving it. It consists of a vial adapter, a syringe adapter, a needle-free connector and sets.
This page is intended for healthcare professionals.
Each part has its own page with every order code.
Closed-System Vial AdapterCloses the vial; 0.2 µm air filter balances pressure.
Needle-Free Syringe AdapterThe closed tip of the syringe; locks on, opens only when connected.
Split Septum Needle-Free ConnectorSplit septum valve on the bag and the line; 7 day barrier.
Oncology Transfer SetLinks the prepared bag to the patient set, primed in the pharmacy.
Oncology Infusion SetOne closed set for the whole session; drugs lock on in turn.
In the pharmacy
It spikes the vial in one move and stays on.
Align the red marks; the two lock together.
Turn the vial over and draw; no open needle, no aerosol.
The dose goes in through the transfer set's valve, then a short flush.
At the chair
With saline, then connect it to the patient's line.
The transfer set locks onto a check valve of the infusion set.
Next drug on the next valve; at the end the set is discarded in one piece.
Figures as given in the supplier's test reports.
NIOSH draft performance protocol with 2-phenoxyethanol, LC-MS/MS: all 20 readings in 5 sets below the 1.96 µg/L quantification limit; the positive control read 44.2 ppb.
Supplier's test report, independent laboratory, July 2025Cisplatin prepared with the closed system and with syringe and needle; four surfaces swabbed on two days, ICP-MS.
Supplier's study, university hospital compounding unit, July 2024No growth of moulds, yeasts, aerobic bacteria, P. aeruginosa or S. aureus in 80 samples over 7 days.
Supplier's study, hospital compounding unit, October 2019Smoke injected through the bellows vial adapter and the syringe adapters: no smoke at any connection.
Supplier's test report, independent laboratory, November 2023in the manufacturer's NIOSH protocol test (July 2025) all 20 measurements in 5 sets and 4 tasks stayed below the quantification limit.
in a 2024 cisplatin study in a university hospital compounding unit the manufacturer reports more than 99 per cent less surface contamination than syringe and needle.
the needle-free valve kept a 7 day barrier over 35 activations in a 2021 university laboratory test.
the parts fit standard luer lock connectors, vials and sets, so ward stock stays the same.
CSTD stands for closed system drug transfer device. NIOSH defines it as a device that mechanically stops contaminants from entering the system and stops hazardous drug or vapour concentrations from leaving it. The system does this with adapters that lock into each other.
A vial adapter, a needle-free syringe adapter, a split septum needle-free connector, an oncology transfer set and an oncology infusion set work together. The vial adapters fit vial necks of 13 to 14 mm and 20 to 21 mm.
A vial adapter is one part of the system: it goes on the vial and closes it. The closed system is the whole path, where the vial adapter, the syringe adapter, the needle-free connector and the sets lock to each other from the vial to the patient.
It keeps the drug inside the path from vial to patient, so no open needle and no open drop is left where the drug is drawn, added to the bag and connected. Whether a closed system is required depends on the standards and regulations your unit follows.
1. The vial adapter goes on the vial. 2. The syringe adapter locks onto the syringe. 3. The red marks are aligned and the two lock. 4. The vial is turned over and the drug is drawn. 5. The dose goes into the bag through the bag adapter or the transfer set's needle-free valve.
UNIQUE laboratory used the NIOSH draft performance protocol with 2-phenoxyethanol as the surrogate and LC-MS/MS analysis; the quantification limit was 1.96 µg/L. The positive control without the system read 44.2 ppb.
The instructions for use say the set and its adapters are discarded together, without being taken apart, as a closed system.
Internationally known systems in this product class include BD PhaSeal, Equashield and Tevadaptor. This page describes the closed system supplied in Türkiye by Melekırmak. The list is not complete and implies no ranking.
NIOSH does not certify closed system transfer devices. It defines the device class and published a draft vapour containment performance protocol in 2015, which manufacturers use to test their own products. A statement that a brand passed the NIOSH test therefore refers to that manufacturer's own test report. For the system on this page, the manufacturer reports a test to the NIOSH draft protocol in July 2025 in which all 20 measurements stayed below the quantification limit. To compare systems, ask each supplier for the test report, the surrogate substance and the quantification limit. This page does not rank brands.
Literature on closed system transfer devices commonly distinguishes two designs: physical-barrier systems and air-filtering (air-cleaning) systems. The vial adapters on this page balance vial pressure with a 0.2 µm hydrophobic air filter, and a bellows vial adapter is listed for 20/21 mm necks. A unit chooses by its own risk assessment and the standards it follows.
USP <800>, the United States standard for handling hazardous drugs in healthcare settings, says a closed system transfer device must be used when administering antineoplastic hazardous drugs if the dosage form allows it, and should be used when compounding them if the dosage form allows it. Whether a closed system is required in your unit depends on the standards and regulations you follow.
The needle-free valve kept a 7 day microbial barrier over 35 activations in a 2021 university laboratory test, and it is listed for up to 200 activations. The 0.2 µm hydrophobic air filter of the vial adapter lets air through while the drug stays sterile. The sets are sterilised with ethylene oxide and are single use.
The price depends on the parts you need (vial adapters, syringe adapters, connectors, sets) and the quantity. Write to us for a fast quote, using the contact details at the foot of this page.
Melekırmak, an Istanbul-based medical device distributor founded in 2006, supplies closed system transfer devices to hospitals across Türkiye and answers international enquiries. Bulk and institutional orders are quoted case by case. For an export order, state the parts you need and the quantity, together with the destination country, and write to us with the contact details at the foot of this page. Availability, documentation and lead times in your country are confirmed in the reply.
Updated: 02.11.2026